BioCentury | Oct 9, 2014
Company News

Deal-maker Max Link passes away

...now PDL BioPharma Inc. (NASDAQ:PDLI), and a $220 million deal with cell separation specialist CellPro Inc....
BioCentury | Mar 31, 2003
Company News

SangStat names Murdock CEO

...director of orthopedic device company Kyphon. Before Kyphon, Murdock was CEO and a director of CellPro...
BioCentury | Apr 29, 2002
Finance

Ebb & Flow

...autoimmune play Corixa (CRXA); cancer company Seattle Genetics (SGEN); and the now-defunct cell separation play CellPro...
...12 times its original investment - on CellPro. Waite said the firm cashed out before CellPro...
BioCentury | Jul 12, 1999
Clinical News

Isolex and Isolex 300i magnetic cell selection systems regulatory update

...sites now operating CellPro Inc .’s Ceprate SC devices, which NEXL purchased as part of CellPro’s...
BioCentury | Jun 21, 1999
Emerging Company Profile

Genespan: Haute (cell) couture

...technical challenge is to culture cells in three dimensions." Goffe previously was a co-founder of CellPro Inc....
BioCentury | Jun 14, 1999
Company News

CellPro gene/cell therapy news

...Corp. Its stock will continue to trade on the OTC BB under the symbol CPRO. CellPro Inc....
BioCentury | May 24, 1999
Company News

NeoRx management update

...Business: Cancer, Cardiovascular Hired: Karen Auditore-Hargreaves as VP of R&D, formerly VP of research at CellPro Inc....
BioCentury | Feb 8, 1999
Company News

Nexell management update

...Amy Ross as VP of diagnostics, formerly senior director of the diagnostics business unit at CellPro Inc. WIR...
BioCentury | Feb 8, 1999
Company News

CellPro, Nexell, VimRx deal

...detect and measure low numbers of residual tumor cells to improve cancer treatments. (Appointment, B8) CellPro Inc....
BioCentury | Jan 25, 1999
Company News

ImClone management update

...VP of product and process development, formerly SVP of R&D and engineering and CTO at CellPro Inc. WIR...
Items per page:
1 - 10 of 135
BioCentury | Oct 9, 2014
Company News

Deal-maker Max Link passes away

...now PDL BioPharma Inc. (NASDAQ:PDLI), and a $220 million deal with cell separation specialist CellPro Inc....
BioCentury | Mar 31, 2003
Company News

SangStat names Murdock CEO

...director of orthopedic device company Kyphon. Before Kyphon, Murdock was CEO and a director of CellPro...
BioCentury | Apr 29, 2002
Finance

Ebb & Flow

...autoimmune play Corixa (CRXA); cancer company Seattle Genetics (SGEN); and the now-defunct cell separation play CellPro...
...12 times its original investment - on CellPro. Waite said the firm cashed out before CellPro...
BioCentury | Jul 12, 1999
Clinical News

Isolex and Isolex 300i magnetic cell selection systems regulatory update

...sites now operating CellPro Inc .’s Ceprate SC devices, which NEXL purchased as part of CellPro’s...
BioCentury | Jun 21, 1999
Emerging Company Profile

Genespan: Haute (cell) couture

...technical challenge is to culture cells in three dimensions." Goffe previously was a co-founder of CellPro Inc....
BioCentury | Jun 14, 1999
Company News

CellPro gene/cell therapy news

...Corp. Its stock will continue to trade on the OTC BB under the symbol CPRO. CellPro Inc....
BioCentury | May 24, 1999
Company News

NeoRx management update

...Business: Cancer, Cardiovascular Hired: Karen Auditore-Hargreaves as VP of R&D, formerly VP of research at CellPro Inc....
BioCentury | Feb 8, 1999
Company News

Nexell management update

...Amy Ross as VP of diagnostics, formerly senior director of the diagnostics business unit at CellPro Inc. WIR...
BioCentury | Feb 8, 1999
Company News

CellPro, Nexell, VimRx deal

...detect and measure low numbers of residual tumor cells to improve cancer treatments. (Appointment, B8) CellPro Inc....
BioCentury | Jan 25, 1999
Company News

ImClone management update

...VP of product and process development, formerly SVP of R&D and engineering and CTO at CellPro Inc. WIR...
Items per page:
1 - 10 of 135